The critical role of gut-brain axis microbiome in mental disorders

被引:0
作者
Kimia Basiji
Azadeh Aghamohammadi Sendani
Shaghayegh Baradaran Ghavami
Maryam Farmani
Nesa Kazemifard
Amir Sadeghi
Ensieh Lotfali
Hamid Asadzadeh Aghdaei
机构
[1] Shahid Beheshti University of Medical Sciences,Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases
[2] Shahid Beheshti University of Medical Sciences,Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases
[3] Shahid Beheshti University of Medical Science,Department of Medical Parasitology and Mycology, School of Medicine
来源
Metabolic Brain Disease | 2023年 / 38卷
关键词
Gut-brain axis; Microbiota; Alzheimer’s disease; Parkinson’s disease; Irritable bowel syndrome; Depression;
D O I
暂无
中图分类号
学科分类号
摘要
The Gut-brain axis is a bidirectional neural and humoral signaling that plays an important role in mental disorders and intestinal health and connects them as well. Over the past decades, the gut microbiota has been explored as an important part of the gastrointestinal tract that plays a crucial role in the regulation of most functions of various human organs. The evidence shows several mediators such as short-chain fatty acids, peptides, and neurotransmitters that are produced by the gut may affect the brain’s function directly or indirectly. Thus, dysregulation in this microbiome community can give rise to several diseases such as Parkinson’s disease, depression, irritable bowel syndrome, and Alzheimer’s disease. So, the interactions between the gut and the brain are significantly considered, and also it provides a prominent subject to investigate the causes of some diseases. In this article, we reviewed and focused on the role of the largest and most repetitive bacterial community and their relevance with some diseases that they have mentioned previously.
引用
收藏
页码:2547 / 2561
页数:14
相关论文
共 458 条
[1]  
Aizawa E(2016)Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder J Affect Disord 202 254-257
[2]  
Tsuji H(2004)Effects of dopamine on ion transport across the rat distal colon Pflügers Archiv 448 605-612
[3]  
Asahara T(2020)Diagnosis and treatment of Parkinson Disease A Review JAMA 145 98-120
[4]  
Takahashi T(2016)Insulin resistance and Parkinson’s disease: a new target for disease modification? Prog Neurobiol 103 263-293
[5]  
Teraishi T(2019)The Alzheimer’s disease clinical spectrum: diagnosis and management Med Clin 20 1482-405
[6]  
Yoshida S(2019)Glutamatergic signaling along the microbiota-gut-brain axis Int J Mol Sci 34 396-417
[7]  
Ota M(2019)Unraveling gut microbiota in Parkinson’s disease and atypical parkinsonism Mov Disord 113 411-9
[8]  
Koga N(2012)γ-Aminobutyric acid production by culturable bacteria from the human intestine J Appl Microbiol 61 1-1285
[9]  
Hattori K(2020)The microbiome-gut-brain axis in acute and chronic brain diseases Curr Opin Neurobiol 12 1239-4749
[10]  
Kunugi H(2021)Diet and the microbiota–gut–brain Axis: sowing the seeds of good Mental Health Adv Nutr 20 4742-2008